CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $40.1 billion by 2034, ...

CRISPR Therapeutics (NasdaqGM:CRSP) experienced an 12% price decline over the last week ... it is wise to be aware of the facts that can impact the stock's prospects. Among them are CRISPR ...

If an investor was to purchase shares of CRSP stock at the current price level of $41.15/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

If an investor was to purchase shares of CRSP stock at the current price level of $43.00/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

Stocks: Real-time U.S. stock quotes reflect trades reported through ... Sources: FactSet, Tullett Prebon Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange ...

CRISPR Therapeutics (NasdaqGM:CRSP) experienced an 12% price decline over the last week ... it is wise to be aware of the facts that can impact the stock's prospects. Among them are CRISPR ...